New App Helps Bowel Disease Patients Monitor Their Own Treatment
This article from the Mid and South Essex NHS Foundation Trust discusses the recent implementation of the BÜHLMANN IBDoc® Calprotectin…
If you have recently been told by your doctor that you require a calprotectin test to help investigate any gastric symptoms you are having, then you may be curious about what this test is. Or, if you have already been diagnosed with inflammatory bowel disease (IBD) such as Crohn’s disease or Ulcerative Colitis, then you may already be familar with the use of calprotectin for the diagnosis and continued monitoring of your condition. In either case you can find out more about calprotectin testing by exploring this website and also discover useful information to help you, such as how to collect a quality sample.
Your calprotectin test will most likely be performed in a clinic or hospital laboratory from a poo sample that you supply. You may be asked to provide this in a small container or you may be given a kit with instructions on how to collect your sample directly into the convenient CALEX® device, that prepares it for immediate testing in the laboratory.
Increasingly more IBD patients are being offered calprotectin home testing for regular monitoring, using the IBDoc® self testing system. IBDoc users will find lots of help and support on this website.
calprotectin.co.uk is supported by Alpha Laboratories Ltd. a diagnostics specialist, who has been the pioneer of calprotectin testing in the UK for over 15 years. We work closely with healthcare professionals and our products are not available for direct sale to patients. Your calprotectin testing will be managed directly by your medical team so please contact them with any questions you may have.
Calprotectin is a protein biomarker that is present in the faeces when intestinal inflammation occurs. Faecal calprotectin testing is helping to improve patient care and save money for the NHS. It prevents the need for unnecessary endoscopy procedures on many patients by screening out those with Irritable Bowel Syndrome (IBS).
The symptoms of functional disorders such as IBS and organic Inflammatory Intestinal Disease (IBD) can be very similar in presentation but are two very different medical conditions.
Historically, clinical gastroenterologists have had to use invasive endoscopy to differentially diagnose between these conditions. NICE [DG11] now recommends the use of faecal calprotectin analysis, as a first-line test, in patients presenting with gastrointestinal symptoms indicative of IBS or IBD. The test can rule out IBD and avoid the need for IBS patients to undergo endoscopy. This prevents patient stress, shortens waiting lists and cuts costs.
Calprotectin is also shown to be of value in the ongoing assessment of known IBD patients, with the biomarker concentration reflecting mucosal healing or potential relapse.
Inflammatory bowel disease is a group of inflammatory conditions of the colon and small intestine. The major types of IBD are Crohn’s disease and Ulcerative Colitis.
Irritable bowel syndrome is a common condition of the digestive system. It can often cause bouts of stomach cramps, bloating, diarrhoea and constipation.
This article from the Mid and South Essex NHS Foundation Trust discusses the recent implementation of the BÜHLMANN IBDoc® Calprotectin…
Calprotectin Testing Goes Mobile With advances in technology and the ubiquitous use of mobile devices, a huge opportunity has arisen to…
Poo Collection Made Easy Collecting poo even gets into the daily news! A recent article in the Daily Mail addressed…